Long-term survival after salvage pemetrexed for refractory primary T-cell lymphoma of the CNS
Primary T-cell CNS lymphoma is a rare and aggressive malignancy. High-dose methotrexate (MTX) based chemotherapy regimens are used as standard first-line treatment, followed by consolidative strategies to improve the duration of response. Although MTX-based therapy has been shown to be efficacious,...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis Group
2023-09-01
|
| Schriftenreihe: | CNS Oncology |
| Schlagworte: | |
| Online-Zugang: | https://www.futuremedicine.com/doi/10.2217/cns-2022-0021 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|